Novel metrics for evaluating decision making in a 'Treat and Extend' regimen for neovascular age related macular degeneration.
Bethan McLeishAnna MorrisMeena KarpoorTehmoor BabarNiro NarendranYit C YangPublished in: Eye (London, England) (2021)
These metrics for evaluating the decision making aspect of disease activity monitoring may be useful for monitoring performance and have given us a more realistic view and expectations of what can be achieved using this regime to optimise the timing of injections.